Activators of AMPK: not just for Type II diabetes

Papers of special note have been highlighted as: • of interest

References

• 1 Hardie DG. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62, 2164–2172 (2013).
  Medline CASGoogle Scholar
• 2 Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol. Cell Endocrinol. 366, 215–223 (2013).
  Medline CASGoogle Scholar
• 3 Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 22, 251–262 (2012).
  Google Scholar
• 4 Gruzman A, Babai G, Sasson S. Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations. Rev. Diabet. Stud. 6, 13–36 (2009).
  MedlineGoogle Scholar
• 5 Sinnett SE, Brenman JE. Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators. Pharmacol. Ther. 143, 111–118 (2014).
  Medline CASGoogle Scholar
• 6 Davies SP, Hawley SA, Woods A et al. Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. Eur. J. Biochem. 223, 351–357 (1994).
  Medline CASGoogle Scholar
• 7 Beri RK, Marley AE, See CG et al. Molecular cloning, expression and chromosomal localisation of human AMP-activated protein kinase. FEBS Lett. 356, 117–21 (1994).
  Medline CASGoogle Scholar
• 8 Stephenne X, Foretz M, Taleux N et al. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 54, 3101–3110 (2011).
  Medline CASGoogle Scholar
• 9 Wu J, Puppala D, Feng X et al. Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK). J. Biol. Chem. 288, 35904–35912 (2013).• Presents a molecular determination of the regulatory mechanism of AMPK action. Extremely important paper for any kind of intellectual drug design of direct AMPK activators.
  Medline CASGoogle Scholar
• 10 Xiao B, Sanders MJ, Underwood E et al. Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230–233 (2011).
  Medline CASGoogle Scholar
• 11 Protein Data Bank Japan. http://service.pdbj.org/mine/Search?position=1&resultSize=16&query=human+AMPK 
  Google Scholar
• 12 Day P, Sharff A, Parra L et al. Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP. Acta Crystallogr. D. Biol. Crystallogr. 63, 587–596 (2007).
  Medline CASGoogle Scholar
• 13 Handa N, Takagi T, Saijo S et al. Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain. Acta Crystallogr. D. Biol. Crystallogr. 67, 480–487 (2011).
  Medline CASGoogle Scholar
• 14 Littler DR, Walker JR, Davis T et al. A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulation. Acta Crystallog. Sect. F Struct. Biol. Cryst. Commun. 66, 143–151 (2010)
  Medline CASGoogle Scholar
• 15 Iseli TJ, Walter M, van Denderen BJ et al. AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186–270). J. Biol Chem. 280, 13395–13400 (2005).
  Medline CASGoogle Scholar
• 16 Wang ZL, Huo JX, Sun LD et al. Computer-aided drug design for AMP-activated protein kinase activators. Curr. Comput. Aided Drug Des. 7, 214–227 (2011)
  MedlineGoogle Scholar
• 17 Russo GL, Russo M, Ungaro P. AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem. Pharmacol. 86, 339–350 (2013).
  Medline CASGoogle Scholar
• 18 Dandapani M, Hardie DG. AMPK: opposing the metabolic changes in both tumor cells and inflammatory cells? Biochem. Soc. Trans. 41, 687–693 (2013).
  Medline CASGoogle Scholar
• 19 Hardie DG, Salt IP, Hawley SA et al. AMP activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338, 717–722 (1999).
  Medline CASGoogle Scholar
• 20 Hawley SA, Davison M, Woods A et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879–27887 (1996).
  Medline CASGoogle Scholar
• 21 Park S, Scheffler TL, Rossie SS et al. AMPK activity is regulated by calcium-mediated protein phosphatase 2A activity. Cell Calcium. 53, 217–223 (2013).
  Medline CASGoogle Scholar
• 22 Kottakis F, Bardeesy N. LKB1–AMPK axis revisited. Cell Res. 22, 1617–1620 (2012).
  Medline CASGoogle Scholar
• 23 Suter M, Riek U, Tuerk R et al. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281, 32207–32216 (2006).
  Medline CASGoogle Scholar
• 24 Peng C, Head-Gordon T. The dynamical mechanism of auto-inhibition of AMP-activated protein kinase. PLoS Comput. Biol. 7, e1002082 (2011).
  Medline CASGoogle Scholar
• 25 Sanchez AM, Candau RB, Csibi A et al. The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis. Am. J. Physiol. Cell Physiol. 303, C475–C485 (2012).
  Medline CASGoogle Scholar
• 26 Scheffler TL, Scheffler JM, Park S et al. Fiber hypertrophy and increased oxidative capacity can occur simultaneously in pig glycolytic skeletal muscle. Am. J. Physiol. Cell Physiol. 306, C354–363 (2014).
  Medline CASGoogle Scholar
• 27 Tanner CB, Madsen SR, Hallowell DM et al. Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1 Am. J. Physiol. Endocrinol. Metab. 305, 1018–29 (2013).
  Google Scholar
• 28 Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev. 93, 993–1017 (2013).
  Medline CASGoogle Scholar
• 29 Friedrichsen M, Mortensen B, Pehmøller C et al. Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol. Cell Endocrinol. 366, 204–214 (2013).
  Medline CASGoogle Scholar
• 30 Mu J, T. Brozinick J, Valladares O et al.A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscles. Mol. Cell, 7, 1085–1094 (2001).
  MedlineGoogle Scholar
• 31 Lefort N, St.-Amand E, Morasse S et al. The α-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am. J. Physiol. Endocrinol. Metab. 295, E1447–E1454 (2008).
  Medline CASGoogle Scholar
• 32 Fujii N, Hirshman M, Kane E et al. AMP-activated protein kinase alpha 2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J. Biol. Chem. 280, 39033–39041 (2005).
  Medline CASGoogle Scholar
• 33 Bijland S, Mancini SJ, Salt IP. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin. Sci. (Lond.) 124, 491–507 (2013).
  Medline CASGoogle Scholar
• 34 Daval M, Foufelle F, Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. 574, 55–62 (2006).
  Medline CASGoogle Scholar
• 35 Dzamko NL, Steinberg GR. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Physiol. (Oxf.) 196, 115–27 (2009).
  Medline CASGoogle Scholar
• 36 Lustig Y, Hemi R, Kanety H. Regulation and function of adiponectin receptors in skeletal muscle. Vitam. Horm. 90, 95–123 (2012).
  Medline CASGoogle Scholar
• 37 Hasenour CM, Berglund ED, Wasserman DH. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Mol. Cell Endocrinol. 366, 152–162 (2013).• Very important work that doubts the physiological relevance of the activation of AMPK by biguanides as a main mechanism of their pharmacological effect.
  Medline CASGoogle Scholar
• 38 Miller R, Chu O, Xie J et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494, 256–261 (2013).
  Medline CASGoogle Scholar
• 39 Miller RA, Birnbaum MJ. An energetic tale of AMPK-independent effects of metformin. J. Clin. Invest. 120, 2267–2269 (2010).
  Medline CASGoogle Scholar
• 40 Jenkins Y, Sun T, Markovtsov V et al. AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes. PLoS ONE 8, e81870 (2013).
  MedlineGoogle Scholar
• 41 Edgerton DS, Johnson KM, Cherrington AD. Current strategies for the inhibition of hepatic glucose production in type 2 diabetes. Front. Biosci. 14, 1169–1181 (2009).
  CASGoogle Scholar
• 42 Foretz M, Hébrard S, Leclerc J et al. Metformin inhibits hepatic gluconeogenesisin mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355–2369 (2010).
  Medline CASGoogle Scholar
• 43 Pfeifer A, Kilić A, Hoffmann LS. Regulation of metabolism by cGMP. Pharmacol. Ther. 140, 81–91 (2013).
  Medline CASGoogle Scholar
• 44 Viollet B, Mounier R, Leclerc J et al. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 33, 395–402 (2007).
  Medline CASGoogle Scholar
• 45 Hawley SA, Ross FA, Chevtzoff C et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11, 554–565 (2010).
  Medline CASGoogle Scholar
• 46 Guigas B, Bertrand L, Taleux N et al. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865–874 (2006).
  Medline CASGoogle Scholar
• 47 Farghali H, Kutinová Canová N, Lekić N. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets. Physiol. Res. 62, 1–13 (2013).
  Medline CASGoogle Scholar
• 48 Nguyen PH, Gauhar R, Hwang SL et al. New dammarane-type glucosides as potential activators of AMP-activated protein kinase (AMPK) from Gynostemma pentaphyllum Bioorg. Med. Chem. 19, 6254–6260 (2011).
  Medline CASGoogle Scholar
• 49 Quan HY, Kim DY, Kim SJ et al. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway. Biochem. Pharmacol. 85, 1330–1340 (2013).
  Medline CASGoogle Scholar
• 50 Guo H, Liu G, Zhong R et al. Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells. Lipids Health Dis. 11, 10 (2012).
  Medline CASGoogle Scholar
• 51 He Y, Li Y, Zhao T et al. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS ONE 8, e70135, (2013).
  Medline CASGoogle Scholar
• 52 Pu P, Wang XA, Salim M et al. Baicalein, a natural product, selectively activating AMPKa2 and ameliorates metabolic disorder in diet-induced mice. Mol. Cell Endocrinol. 362, 128–138 (2012).
  Medline CASGoogle Scholar
• 53 Yoon SA, Kang SI, Shin HS et al. p-coumaric acid modulates glucose and lipid metabolism via AMP-activated protein kinase in L6 skeletal muscle cells. Biochem. Biophys. Res. Commun. 432, 553–557 (2013).
  Medline CASGoogle Scholar
• 54 Kubra IR, Rao LJ. An impression on current developments in the technology, chemistry, and biological activities of ginger. Crit. Rev. Food Sci. Nutr. 52, 651–88 (2012).
  Medline CASGoogle Scholar
• 55 Quan HY, Kim SJ, Kim DY et al. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase. Fitoterapia 86, 208–216 (2013).
  Medline CASGoogle Scholar
• 56 Zhou R. Wang L. Xu X et al. Danthron activates AMP-activated protein kinase and regulates lipid and glucose metabolism in vitro. Acta Pharmacol. Sin. 34, 1061–1069 (2013).
  MedlineGoogle Scholar
• 57 Guo H, Zhao H, Kanno Y et al. A dihydrochalcone and several homoisoflavonoids from Polygonatum odoratum are activators of adenosine monophosphate-activated protein kinase. Bioorg. Med. Chem. Lett. 23, 3137–3139 (2013).
  Medline CASGoogle Scholar
• 58 Singhal SS, Figarola J, Singhal J et al. 1, 3-bis(3,5-dichlorophenyl) urea compound ‘COH-SR4’ inhibits proliferation and activates apoptosis in melanoma. Biochem. Pharmacol. 84, 1419–1427 (2012).
  Medline CASGoogle Scholar
• 59 Figarola J, Rahbar S. Small molecule COH-SR4 inhibits adipocyte differentiation via AMPK activation. Int. J. Mol. Med. 31, 1166–1176 (2013).
  Medline CASGoogle Scholar
• 60 Lian Z, Li Y, Gao J et al. A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells. Lipids Health Dis. 10, 67 (2011).
  Medline CASGoogle Scholar
• 61 Oh S, Kim SJ, Hwang JH et al. Effects of ampkinone (6f), a novel small molecule activator of amp-activated protein kinase. J. Med. Chem. 53, 7405–7413 (2010).
  Medline CASGoogle Scholar
• 62 Shen S, Zhuang J, Chen Y et al. Synthesis and biological evaluation of arctigenin ester and ether derivatives as activators of AMPK Bioorg. Med. Chem. 21, 3882–3893 (2013).
  CASGoogle Scholar
• 63 Tripodi F, Pagliarin R, Fumagalli G et al. Synthesis and biological evaluation of 1,4- diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis. J. Med. Chem. 55, 2112–2124 (2012)
  Medline CASGoogle Scholar
• 64 Sviripa V, Zhang W, Conroy MD et al. Fluorinated N, N-diarylureas as AMPK activators. Bioorg. Med. Chem. Lett. 23, 1600–1603 (2013)
  Medline CASGoogle Scholar
• 65 Chen D, Pamu S, Cui Q et al. Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg. Med. Chem. 20, 3031–3037 (2012).
  Medline CASGoogle Scholar
• 66 Shieh JM, Chen YH, Lin YC et al. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. J. Agric. Food Chem. 61, 6366–6375 (2013).
  Medline CASGoogle Scholar
• 67 Kim JH, Lee JO, Lee SK et al. Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53–polo like kinase 2 (PLK-2) pathway. Cell. Signal. 25, 805–813 (2013).
  Medline CASGoogle Scholar
• 68 Wang B, Wang XB, Chen LY et al. Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochem. Biophys. Res. Commun. 437, 1–6 (2013).
  Medline CASGoogle Scholar
• 69 He XY, Liu XJ, Chen X et al. Gambogic acid induces EGFR degradation and Akt/mTORC1 inhibitionthrough AMPK dependent-LRIG1 upregulation in cultured U87 glioma cells. Biochem. Biophys. Res. Commun. 435, 397–402 (2013).
  Medline CASGoogle Scholar
• 70 Ding D, Zhang B, Meng T et al. Novel synthetic baicalein derivatives caused apoptosis and activated AMP-activated protein kinase in human tumor cells. Org. Biomol. Chem. 9, 7287–7291 (2011).
  Medline CASGoogle Scholar
• 71 Lu J, Wu D-M, Zheng Y-L et al. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol- induced neurotoxicity. J. Pathol. 222, 199–212 (2010).
  Medline CASGoogle Scholar
• 72 Daniel B, Green O, Viskind O et al. Riluzole increases the rate of glucose transport in L6 myotubes and NSC-34motor neuron-like cells via AMPK pathway activation. Amyotroph. Lateral. Scler. Frontotemporal Degener. 14, 434–443 (2013).
  Medline CASGoogle Scholar
• 73 Weisova P, Alvarez SP, Kilbride SM et al. Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability. Transl. Psychiatry 3, e317 (2013)
  Medline CASGoogle Scholar
• 74 Xie L, Li W, Winters A et al. Methylene blue induces macroautophagy through 5´- adenosine monophosphate activated protein kinase pathway to protect neurons from serum deprivation. Front. Cell. Neurosci. 7, 56 (2013).
  Medline CASGoogle Scholar
• 75 Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J. Med. Toxicol. 9, 242–249.(2013).
  Medline CASGoogle Scholar
• 76 Vingtdeux V, Chandakkar P, Zhao H et al. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid- peptide degradation. FASEB J. 25, 219–231 (2011).
  Medline CASGoogle Scholar
• 77 Vingtdeux V, Chandakkar P, Zhao H et al. Small-molecule activators of AMP- activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis. Mol. Med. 17, 1022–1030 (2011).
  Medline CASGoogle Scholar
• 78 Nguyen PH, Le TV, Kang HW et al. Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation. Br. J. Pharmacol. 168, 932–945 (2013).
  MedlineGoogle Scholar
• 79 Song CY, Shi J, Zeng X et al. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Toxicol. In Vitro 27, 1065–1071 (2013).
  Medline CASGoogle Scholar
• 80 Guh JH, Chang WL, Yang J et al. Development of novel adenosine monophosphate-activated protein kinase activators. J. Med. Chem. 53, 2552–2561 (2010)
  Medline CASGoogle Scholar
• 81 Filipov S, Pinkosky SL, Lister RJ et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J. Lipid Res. 54, 2095–2108 (2013).
  MedlineGoogle Scholar
• 82 Ballantyne CM, Davidson M, MacDougall M et al. ETC-1002 lowers LDL-C and beneficially modulates other cardio-metabolic risk factors in hypercholesterolemic subjects with either normal or elevated triglycerides. J. Am. Coll. Cardiol. 59, E1625–E1625 (2012).
  Google Scholar
• 83 Park SH, Huh TL, Kim SY et al. Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial. Obesity 22, 63–71 (2014).
  Medline CASGoogle Scholar
• 84 Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 12, 53–63 (1994).
  Medline CASGoogle Scholar
• 85 Pakrashi A, Pakrasi P. Biological profile of p-coumaric acid isolated from Aristolochia indica Linn. Indian J. Exp. Biol. 16, 1285–1287 (1978).
  Medline CASGoogle Scholar
• 86 Quinde-Axtell Z, Baik BK. Phenolic compounds of barley grain and their implication in food product discoloration. J. Agric. Food Chem. 54, 9978–9984 (2006).
  Medline CASGoogle Scholar
• 87 Stojkovic D, Petrovic J, Sokovic M et al. In situ antioxidant and antimicrobial activities of naturally occurring caffeic acid, p-coumaric acid and rutin, using food systems. J. Sci. Food Agric. 93, 3205–3208 (2013).
  Medline CASGoogle Scholar
• 88 Gomez-Zorita S, Tréguer K, Mercader J et al. Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells. J. Physiol. Biochem. 69, 585–593 (2013).
  Medline CASGoogle Scholar
• 89 Ferguson L, Zhu S, Harris P. Antioxidant and antigenetic effects of plant cell wall hydroxyl cinnamic acid in cultured HT-29 cells. Mol. Nutr. Food Res. 49, 585–593 (2005).
  Medline CASGoogle Scholar
• 90 Roy AJ, Prince SM. Preventive effects of p-coumaric acid on lysosomal dysfunction and myocardial infarct size in experimentally induced myocardial infarction. Eur. J. Pharm. 699, 33–39 (2013).
  Medline CASGoogle Scholar
• 91 An SM, Lee SI, Choi SW et al. p-coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by alpha-melanocyte stimulating hormone. Br. J. Dermatol. 159, 292–299 (2008).
  Medline CASGoogle Scholar
• 92 Lee SI, An SM, Mun GI et al. Protective effect of Sasa quelpaertensis and p-coumaric acid on ethanol-induced hepatotoxicity in mice. J. Appl. Biol. Chem. 51, 148–154 (2008).
  CASGoogle Scholar
• 93 Leiherer A, Mündlein A, Drexel H. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul. Pharmacol. 58, 3–20 (2013).
  Medline CASGoogle Scholar
• 94 Chakraborty D, Mukherjee A, Sikdar S et al. [6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicol. Lett. 210, 34–43 (2012).
  Medline CASGoogle Scholar
• 95 Li Y, Tran VH, Duke CC et al. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med. 78, 1549–1555 (2012).
  Medline CASGoogle Scholar
• 96 Li Y, Tran VH, Koolaji N et al. (S)-[6]-Gingerol enhances glucose uptake in L6 myotubes by activation of AMPK in response to [Ca²⁺] J. Pharm. Pharm. Sci. 16, 304–312, (2013).
  Medline CASGoogle Scholar
• 97 Mullauer FB, Kessler JH, Medema JP. Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs 21, 215–27 (2010).
  Medline CASGoogle Scholar
• 98 Fulda S, Scaffidi C, Susin SA et al. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273, 33942–33948 (1998).
  Medline CASGoogle Scholar
• 99 Fulda S, Kroemer G. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov. Today 14, 885–890 (2009).
  Medline CASGoogle Scholar
• 100 Viollet B, Guigas B, Leclerc J et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol. 196, 81–98 (2009).
  Medline CASGoogle Scholar
• 101 Mosqueda-Garcia R. Adenosine as a therapeutic agent. Clin. Invest. Med. 15, 445–455 (1992).
  Medline CASGoogle Scholar
• 102 Łabuzek K, Liber S, Gabryel B et al. Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol. Rep. 62, 827–848 (2010)• Important report about the AMPK-independent antiproliferative effect of metformin.
  Medline CASGoogle Scholar
• 103 Ben Sahra I, Regazzetti C, Robert G et al.Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1 Cancer Res. 71, 4366–4372 (2011).
  Medline CASGoogle Scholar
• 104 Ouyang J, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase. J. Biol. Chem. 286, 1–11 (2011).
  Medline CASGoogle Scholar
• 105 Kola B. Role of AMP-activated protein kinase in the control of appetite. J. Neuroendocrinol. 20, 942–951 (2008). • Comprehensive review about the controversial role of AMPK in the physiology of β cells.
  Medline CASGoogle Scholar
• 106 Fu A, Eberhard CE, Screaton RA. Role of AMPK in pancreatic beta cell function. Mol. Cell Endocrinol. 366, 127–134 (2013).
  Medline CASGoogle Scholar
• 107 Evans JM, Donnelly LA, Emslie-Smith AM et al. Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503), 1304–1305 (2005).
  MedlineGoogle Scholar
• 108 Liang J, Gordon B, Mills GB. AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 73, 2929–2935 (2013).
  Medline CASGoogle Scholar
• 109 Dunlop EA, Tee AR. The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis. Biochem Soc Trans. 41, 939–943 (2013).
  Medline CASGoogle Scholar
• 110 Lee CW, Wong LL, Tse EY et al. AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res. 72, 4394–4404 (2012).
  Medline CASGoogle Scholar
• 111 Xu J, Ji J, Yan XH. Cross-talk between AMPK and mTOR in regulating energy balance. Crit. Rev. Food Sci. Nutr. 52, 373–381 (2012).
  Medline CASGoogle Scholar
• 112 Li C, Liu VW, Chiu PM et al. Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications. BMC Cancer 12, 357 (2012).
  Medline CASGoogle Scholar
• 113 Kato K, Ogura T, Kishimoto A et al. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21, 6082–6090 (2002).
  Medline CASGoogle Scholar
• 114 Park HU, Suy S, Danner M et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol. Cancer Ther. 8, 733–741 (2009).
  Medline CASGoogle Scholar
• 115 Kim YH, Liang H, Liu X et al. AMPK alpha modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Res. 72, 2512–2521 (2012).
  Medline CASGoogle Scholar
• 116 Shackelford DB, Abt E, Gerken L et al.LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23, 143–58 (2013).
  Medline CASGoogle Scholar
• 117 Faubert B, Vincent EE, Poffenberger NC et al. The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator. Cancer Lett. doi:10.1016/j.canlet.2014.01.018 (2014) (Epub ahead of print).
  MedlineGoogle Scholar
• 118 Lettieri BD, Vegliante R, Desideri E et al. Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy. Biochim. Biophys. Acta 1845(2), 317–324 (2014).
  MedlineGoogle Scholar
• 119 Faubert B, Boily G, Izreig S et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17, 113–24 (2012).
  MedlineGoogle Scholar
• 120 Banik BK, Banik I, Becker FF. Novel anticancer-lactams. Top. Heterocycl. Chem. 22, 349–373 (2010).
  CASGoogle Scholar
• 121 Smith DM, Kazi A, Smith L et al.A novel beta-lactam antibiotic activates tumor cell apoptotic program by inducing DNA damage. Mol. Pharmacol. 61, 1348–1358 (2002).
  Medline CASGoogle Scholar
• 122 Wu CL, Qiang L, Han W et al. Role of AMPK in UVB-induced DNA damage repair and growth control. Oncogene 32, 2682–2689 (2013).
  Medline CASGoogle Scholar
• 123 McKeown E, Nelson DW, Johnson EK et al. Current approaches and challenges for monitoring treatment response in colon and rectal cancer. J. Cancer 5, 31–43 (2014).
  MedlineGoogle Scholar
• 124 Shirakami Y, Shimizu M, Moriwaki H. Cancer chemoprevention with green tea catechins: from bench to bed. Curr. Drug Targets 13, 1842–1857 (2012).
  Medline CASGoogle Scholar
• 125 Lee JH, Won YS, Park KH et al. Celastrol inhibits growth and induces apoptotic cell deathin melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling. Apoptosis 17, 1275–1286 (2012).
  Medline CASGoogle Scholar
• 126 Madhunapantula SV, Mosca PJ, Robertson GP. The Akt signaling pathway: an emerging therapeutic target in malignant melanoma. Cancer Biol. Ther. 12, 1032–1049 (2011).
  Medline CASGoogle Scholar
• 127 Tozawa K, Sagawa M, Kizaki M. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway. Int. J. Oncol. 39, 1117–1122 (2011).
  Medline CASGoogle Scholar
• 128 Aggarwal B, Prasad S, Sung B et al. Prevention and treatment of colorectal cancer by natural agents from mother nature. Curr. Colorectal Cancer Rep. 9, 37–56 (2013).
  MedlineGoogle Scholar
• 129 O'Toole SA, Beith JM, Millar EK et al. Therapeutic targets in triple negative breast cancer. J. Clin. Pathol. 66, 530–542 (2013).
  MedlineGoogle Scholar
• 130 Arendos M, Bihan C, Delaloge S et al. Triple-negative breast cancer: are we making headway at least? Ther. Adv. Med. Oncol. 4, 195–210 (2012).
  MedlineGoogle Scholar
• 131 Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 34, 307–316 (2013).
  Medline CASGoogle Scholar
• 132 Nagpal K, Singh SK, Mishra DN. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opin. Drug Deliv. 10, 927–955 (2013).
  Medline CASGoogle Scholar
• 133 Liu X, Chhipa RR, Pooya S et al. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc. Natl Acad. Sci. USA 111, E435–E444 (2014).
  Medline CASGoogle Scholar
• 134 Dienel DA, Hertz L. Glucose and lactate metabolism during brain activation. J. Neurosci. Res. 66, 824–838 (2001).
  Medline CASGoogle Scholar
• 135 Culmsee C, Monnig J, Kemp BE et al. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J. Mol. Neurosci. 17, 45–58 (2001).
  Medline CASGoogle Scholar
• 136 Gadalla AE, Pearson T, Currie AJ et al. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. J. Neurochem. 88, 1272–1282 (2004).
  Medline CASGoogle Scholar
• 137 McCullough LD, Zeng Z, Li H et al. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J. Biol. Chem. 280, 20493–20502 (2005).
  Medline CASGoogle Scholar
• 138 Ramamurthy S, Ronnett G. AMP-activated protein kinase (AMPK) and energy- sensing in the brain. Exp. Neurobiol. 21, 52–60 (2012).
  MedlineGoogle Scholar
• 139 Spasic MR, Callaerts P, Norga KK. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons. Neuroscientist 15, 309–316 (2009).
  Medline CASGoogle Scholar
• 140 Hageman SA, Ellis TK, Fu LJ et al. Trans-(-)-viniferin increases mitochondrial Sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J. Biol. Chem. 287, 24460–24472 (2012).
  MedlineGoogle Scholar
• 141 Vingtdeux V, Davies P, Dickson DW et al. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. 121, 337–349 (2011).
  Medline CASGoogle Scholar
• 142 Morentin PB, Gonzalez CR, Lopez M. AMP-activated protein kinase: ‘a cup of tea’ against cholesterol-induced neurotoxicity. J. Pathol. 222, 329–334 (2010).
  MedlineGoogle Scholar
• 143 Zhu K, Chen X, Liu J et al. AMPK interacts with DSCAM and plays an important role in Netrin-1 induced neurite outgrowth. Protein Cell 4, 155–161 (2013).
  Medline CASGoogle Scholar
• 144 Kima J, Parka YL, Janga Y et al. AMPK activation inhibits apoptosis and tau hyperphosphorylation mediated by palmitate in SH-SY5Y cells. Brain Res. 1418, 42–51 (2011).
  MedlineGoogle Scholar
• 145 Paintlia AS, Paintlia MK, Mohan S et al. AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am. J. Pathol. 183, 526–541 (2013).
  Medline CASGoogle Scholar
• 146 Choi IY, Ju C, Jalin A et al. Activation of cannabinoid CB2 receptore mediated AMPK/CREB pathway reduces cerebral ischemic injury. Am. J. Pathol. 182, 928–939 (2013).
  Medline CASGoogle Scholar
• 147 Kim SJ, Lee JH, Chung HS et al. Neuroprotective effects of AMP-activated protein kinase on scopolamine induced memory impairment. Korean J. Physiol. Pharmacol. 17, 331–338 (2013).
  Medline CASGoogle Scholar
• 148 Kwon KJ, Kim HJ, Shin CY et al. Melatonin potentiates the neuroprotective properties of Resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J. Clin. Neurol. 6, 127–137 (2010).
  MedlineGoogle Scholar
• 149 Ju TH, Chen HM, Lin JT et al. Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington's disease. J. Cell Biol. 194, 209–227 (2011).
  Medline CASGoogle Scholar
• 150 Cardaci S, Filomeni G, Ciriolo MR et al. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J. Cell Sci. 125, 2115–2125 (2012).
  Medline CASGoogle Scholar
• 151 Manwani B, McCullough LD. Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke. J. Neurosci. Res. 91, 1018–1029 (2013)
  Medline CASGoogle Scholar
• 152 Lee Y, Morrison BM, Li Y et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443–448 (2012).
  Medline CASGoogle Scholar
• 153 Dajas F. Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 143, 383–396 (2012).
  Medline CASGoogle Scholar
• 154 Ferry DR, Smith A, Malkhandi J et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res.2, 659–668 (1996).
  Medline CASGoogle Scholar
• 155 Cifra A, Mazzone GL, Nistri A. Riluzole: what it does to spinal and brainstem neurons and how it does it. Neuroscientist 19, 137–144 (2013).
  MedlineGoogle Scholar
• 156 Vannucci SJ, Reinhart R, Maher F et al. Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischaemia in the immature rat brain. Brain Res. Dev. Brain Res. 107, 255–264 (1998).
  Medline CASGoogle Scholar
• 157 Delgado-Esteban M, Almeida A, Bolaños JP. D-glucose prevents glutathione oxidation and mitochondrial damage after glutamate receptor stimulation in rat cortical primary neurons. J. Neurochem. 75, 1618 – 1624 (2000).
  Medline CASGoogle Scholar
• 158 Vergun O, Han YY, Reynolds IJ. Glucose deprivation produces a prolonged increase in sensitivity to glutamate in cultured rat cortical neurons. Exp. Neurol. 183, 682–694 (2003).
  Medline CASGoogle Scholar
• 159 Lu DY, Huang BR, Yeh WL et al. Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells. Mol. Neurobiol. 48, 863–874 (2013).
  Medline CASGoogle Scholar
• 160 Benarroch EE. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 81, 1079–1088 (2013).
  MedlineGoogle Scholar
• 161 Pallàs M, Camins A. Molecular and biochemical features in Alzheimer's disease. Curr. Pharm. Des. 12, 4389–4408 (2006).
  Medline CASGoogle Scholar
• 162 Culmsee C, Monnig J, Kemp BE et al. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J. Mol. Neurosci. 17, 45–58 (2001).
  Medline CASGoogle Scholar
• 163 Dagon Y, Avraham Y, Magen I et al. Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. J. Biol. Chem. 280, 42142–42148 (2005).
  Medline CASGoogle Scholar
• 164 Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl Acad. Sci. USA 104, 7217–7222 (2007).
  Medline CASGoogle Scholar
• 165 Capiralla H, Vingtdeux V, Zhao H et al. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J. Neurochem. 120, 461–472 (2012).
  Medline CASGoogle Scholar
• 166 Davies P. A very incomplete comprehensive theory of Alzheimer's disease. Ann. NY Acad. Sci. 924, 8–16 (2000).
  Medline CASGoogle Scholar
• 167 Racioppi L, Means AR. Calcium/calmoduli-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J. Biol. Chem. 287, 31658–31665 (2012).
  Medline CASGoogle Scholar
• 168 Nguyen PH, Le TV, Kang HW et al. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg. Med. Chem. Lett. 20, 4128–4131 (2010).
  Medline CASGoogle Scholar
• 169 Hien TT, Ki SH, Yang JW et al. Nectandrin B suppresses the expression of adhesion molecules in endothelial cells: Role of AMP-activated protein kinase activation. Food Chem. Toxicol. 66, 286–294 (2014).
  Medline CASGoogle Scholar
• 170 Silvestre-Roig C, Fernández P, Esteban V et al. Inactivation of nuclear factor-Y inhibits vascular smooth muscle cell proliferation and neointima formation. Arterioscler. Thromb. Vasc. Biol. 33, 1036–1045 (2013).
  Medline CASGoogle Scholar
• 171 Lihn AS, Pedersen SB, Lund S et al. The antidiabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol. Cell. Endocrinol. 292, 36–41 (2008).
  Medline CASGoogle Scholar
• 172 Sag D, Carling D, Stout RD et al. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633–8641 (2008).
  Medline CASGoogle Scholar
• 173 Yang D, Xue B, Wang X et al. 2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase. PLoS ONE 8, e64932 (2013).• First report about the ability of metformin to directly activate AMPK.
  Medline CASGoogle Scholar
• 174 Zhang Y, Wang Y, Bao C et al. Metformin interacts with AMPK through binding to subunit. Mol. Cell Biochem. 368, 69–76 (2012).
  Medline CASGoogle Scholar
• 175 Wang Z, Wang X, Qu K et al. Binding of cordycepin monophosphate to AMP-activated protein kinase and its effect on AMP-activated protein kinase activation. Chem. Biol. Drug Des. 76, 340–344 (2010).
  Medline CASGoogle Scholar
• 176 Hawley SA, Fullerton MD, Ross FA et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918–922 (2012).
  Medline CASGoogle Scholar
• 177 Cool B, Zinker B, Chiou W et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403–416 (2006).• Very important work that reviles molecular basis of activation of AMPK by small molecules.
  Medline CASGoogle Scholar
• 178 Treebak JT, Birk JB, Hansen BF et al. A-769662 activates AMPK 1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 297, C1041–C1052 (2009).
  Medline CASGoogle Scholar
• 179 Liu Y, Oh SG, Chang KH et al. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Biochem. Pharmacol. 86, 914–925 (2013).
  Medline CASGoogle Scholar
• 180 Pang T, Zhang ZS, Gu M et al. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells. J. Biol. Chem. 283, 16051–1660 (2008).
  Medline CASGoogle Scholar
• 181 Meltzer-Mats E, Babai G, Pasternak L et al. Synthesis and mechanism of anti- hyperglycemic activity of benzothiazole derivatives. J. Med. Chem. 56, 5335–5350 (2013)
  Medline CASGoogle Scholar
• 182 Yu LF, Li YY, Su MB et al. Development of novel alkene oxindole derivatives as orally efficacious AMP-activated protein kinase activators. ACS Med. Chem. Lett. 4, 475–480 (2013).• Summarizes work for design, synthesis and biological evaluation of a novel potent AMPK direct activator.
  Medline CASGoogle Scholar
• 183 Mirguet O, Sautet S, Clément CA et al. Discovery of pyridones as oral AMPK direct activators. ACS Med. Chem. Lett. 4, 632–636 (2013).▪ Summarizes work for design, synthesis and biological evaluation of a novel potent AMPK direct activator.
  Medline CASGoogle Scholar
• 184 Gomez-Galeno GE, Dang Q, Nguyen TH et al. A potent and selective AMPK activator that inhibits de novo lipogenesis. ACS Med. Chem. Lett. 1, 478–482 (2010).
  Medline CASGoogle Scholar
• 185 Choi J, He N, Sung MK et al. Sanguinarine is an allosteric activator of AMP- activated protein kinase. Biochem. Biophys. Res. Comm. 413, 259–263 (2011).
  Medline CASGoogle Scholar
• 186 Paterson RR. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69, 1469–1495 (2008).
  Medline CASGoogle Scholar
• 187 Tuli HS, Sharma AK, Sandhu SS et al. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 93, 863–869 (2013).
  Medline CASGoogle Scholar
• 188 Alpert E, Gruzman A, Tennenbaum T et al. Selective cyclooxygenase-2 inhibitors stimulate glucose transport in L6 myotubes in a protein kinase C -dependent manner. Biochem. Pharmacol. 73, 368–377 (2007).
  Medline CASGoogle Scholar
• 189 Fleischman A, Shoelson SE, Bernier R et al. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289–294 (2008).
  Medline CASGoogle Scholar
• 190 Goldfine AB, Fonseca V, Jablonski KA et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346–357 (2010).• Amazing discovery that salicylates activate AMPK. These data explain the old evidence about antidiabetic action of salycilates.
  MedlineGoogle Scholar
• 191 Xiao B, Sanders MJ, Carmena D et al. Structural basis of AMPK regulation by small molecule activators. Nat. Commun. 4, 3017 (2013).
  MedlineGoogle Scholar
• 192 Foukas LC, Withers DJ. Phosphoinositide signaling pathways in metabolic regulation. Curr. Top Microbiol. Immunol. 346, 115–141 (2013).
  Google Scholar
• 193 Kim AS, Miller EJ, Wright TM et al. A small molecule AMPK activator protects the heart against ischemia–reperfusion injury. J. Mol. Cell. Cardiol. 51, 24–32 (2011).
  Medline CASGoogle Scholar
• 194 Chen L, Jiao ZH, Zheng LS et al. Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature 459, 1146–1149 (2009).
  Medline CASGoogle Scholar
• 195 Pang T, Xiong B, Li JY et al. Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J. Biol. Chem. 282, 495–506 (2007).
  Medline CASGoogle Scholar
• 196 Mackraj I, Govender T, Gathiram P. Sanguinarine. Cardiovasc. Ther. 26, 75–83 (2008).
  Medline CASGoogle Scholar